DeepCare Labs
DeepCare Labs
Addiction medicine still relies on trial-and-error protocols and clinical intuition. Albert Burgess-Hull, PhD, looks at what oncology, neurology, and autoimmune disease have built instead – computational frameworks that predict individual treatment response rather than reacting to it – and asks why addiction medicine hasn’t built the same infrastructure yet.
Addiction medicine still prescribes, waits, and reacts – while other specialties have built the tools to predict treatment response early in treatment. Here’s what’s stopping us from doing the same.
Overdose deaths are falling, yet the treatment gap keeps growing. The numbers behind why the addiction treatment system cannot meet demand – and won’t, without new infrastructure.
The biggest problem facing addiction medicine is not the treatments – it’s the infrastructure surrounding care. Three structural failures, and a two-phase plan to fix them.
Occasional notes from the DeepCare Labs team on addiction-care infrastructure. No cadence promises – we write when there’s something worth sharing.